Stericycle (NASDAQ: SRCL) reported Q2 EPS of $1.15, $0.02 better than the analyst estimate of $1.13. Revenue for the quarter came in at $917.7 million versus the consensus estimate of $903.79 million.

SECOND QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR:

• Revenues of $917.7 million, an increase of 2.9%, including a 1.3% unfavorable impact from foreign exchange
• Gross profit of $381.8 million, an increase of 1.1%
• Reached proposed settlement of class action lawsuit of $295.0 million to reduce uncertainty and expense of continued litigation
• Loss per share of $1.74, due primarily to the impact of the proposed class action settlement, and Adjusted earnings per share (“Adjusted EPS”) of $1.15

For earnings history and earnings-related data on Stericycle (SRCL) click here.